Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granule in Postoperative Resectable Pancreatic Cancer
NCT06368063Phase 4Recruiting
- Sponsor
- Xi'an Jiaotong University
- Start
- May 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of huaier granule in pancreatic cancer (PC), sponsored by Xi'an Jiaotong University. Started May 2024; status: recruiting.
02
Drugs
huaier granule
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT06368063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06368063.